BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4459730)

  • 1. [On the use of cinnarizine dihydrochloride in the treatment of arteriosclerotic cerebropathy].
    Di Lorenzo S; Costagliola A; Lampasi D; Alfano S
    Minerva Cardioangiol; 1974 Dec; 22(12):867-70. PubMed ID: 4459730
    [No Abstract]   [Full Text] [Related]  

  • 2. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years.
    Hunyi L
    Ther Hung; 1974; 22(1):32-4. PubMed ID: 4844929
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of cyclandelate on psychological test performance in patients with cerebral vascular insufficiency.
    Smith WL; Lowrey JB; Davis JA
    Curr Ther Res Clin Exp; 1968 Dec; 10(12):613-8. PubMed ID: 4972756
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cinnarizine and phosphatidyl choline in the treatment of cerebral arteriosclerotic pathology and arteriosclerosis of the lower extremities. Comparative study].
    Ciammaichella A; Solitro A; Arcuri P
    Minerva Cardioangiol; 1975 Mar; 23(3):191-200. PubMed ID: 1128771
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with Cinnarizin (Stugeron) in the treatment of arteriosclerotic and post-traumatic psychosyndromes].
    Voina S
    Schweiz Rundsch Med Prax; 1970 Aug; 59(32):1165-70. PubMed ID: 5513338
    [No Abstract]   [Full Text] [Related]  

  • 6. [Taurine in the treatment of diffuse cerebral arteriopathies. Clinical and electroencephalographic observations and psychological tests].
    Montanini R; Gasco P
    Clin Ter; 1974 Dec; 71(5):427-36. PubMed ID: 4448048
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of cinnarizine in patients with cerebral circulatory deficiency.
    Toledo JB; Pisa H; Marchese M
    Arzneimittelforschung; 1972 Feb; 22(2):448-51. PubMed ID: 4554633
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
    Lefebvre P; Crocq L; Bernard JG
    Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of procaine chlorhydrate in arteriosclerotic patients and mental functions].
    Colucci D'Amato F; Rogliani G; Feis P
    Acta Neurol (Napoli); 1975; 30(5):510-4. PubMed ID: 779410
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
    Reimann-Hunziker R; Reimann-Hunziker GJ
    Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of taurine on initial senile cerebral involution].
    Fanciullacci M; Franchi G; Sicuteri F; Suman A
    Clin Ter; 1974 Sep; 70(5):425-33. PubMed ID: 4421446
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinicopharmacological examination of Stugeron (Cinnarizine) in geriatric patients.
    Graber H; Ternovszky E
    Ther Hung; 1978; 26(3):124-6. PubMed ID: 725815
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic results with 1035 MD (apropos of 92 cases)].
    Delteil P; Douche F; Fromentin M
    Ann Med Psychol (Paris); 1971 Feb; 1(2):261-8. PubMed ID: 5577431
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sturgeron treatment effectiveness in early cerebral arteriosclerosis].
    Belonog RP; Karaban' IN
    Vrach Delo; 1980 Sep; (9):67-9. PubMed ID: 7423956
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience in the treatment of leg ulcer with Stutgeron].
    Mund-Hoym WD
    Med Welt; 1976 Jun; 27(25):1251-4. PubMed ID: 933813
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trial of cinnarizine in some vascular diseases].
    Triandaf I; Cosma M; Triandaf N
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(1):19-22. PubMed ID: 135327
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of a cerebral vasoactive drug, 1035 MD, in 40 adolescents with severe mental retardation].
    Rossignol C
    Rev Neuropsychiatr Infant; 1972 Oct; 20(10):791-7. PubMed ID: 4650286
    [No Abstract]   [Full Text] [Related]  

  • 18. [Place of combined cinnarizine-heptanol acefyllinate in treatment of vertigo and ear buzzing of vascular origin].
    Calvet J; Coll J; Stefani JM
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Feb; 18(2):127-30. PubMed ID: 4392741
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of Vascoril].
    Bernasconi P
    Lille Med; 1973 Feb; 18():Suppl 2:237-40. PubMed ID: 4732954
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolonged clinical experimentation with MD-1036 in coronary angina].
    Routier MG
    J Sci Med Lille; 1972 Oct; 90(10):359-62. PubMed ID: 4629441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.